Director
Head of the groups "Conflicts of interest and bias" and "Therapy response and therapy response predicition"
Specialist in psychiatry and psychotherapy
+49 6131 17-7335
+49 6131 17-477336Co-Leader of the goup "Conflicts of interest and bias"
Specialist in internal medicine
Specialist in public health
PD Dr. Nadine Dreimüller
Marlene Stoll, M.Sc.
Dr. Cora Koch
Lara Hubenschmid, M.Sc.
Janosch Weißkircher, M.A.
Medical and scientific thinking and action should always be oriented toward the patient's well-being. However, physicians always find themselves in a system of diverging interests and options for action. Direct financial conflicts of interest and indirect conflicts of interest can (un)consciously influence judgment and decision-making and may impair patient welfare. Physicians are exposed to a particularly strong influence by the pharmaceutical industry, which depends on the medical profession for its business success. However, physicians are also exposed to increasing pressure to take financial considerations into account in their medical professional actions, particularly in hospitals.
In everyday clinical practice as well as in research, questions such as the following arise: How do physicians perceive non-medical influence on their actions? Are they aware of conflicts of interest? How do they deal with them? How do they behave when the patient's well-being is endangered by non-medical influences? What is their position on regulations for dealing with conflicts of interest?
This also raises the question of how the patient's preferences can be clarified and translated into medical action in the process of shared decision-making between physician and patient.
Threats to the integrity of clinical medicine and medical research are the guiding theme of our working group.
The project SoCIReM (Second order effects of Conflict of Interest Regulations in Medicine) is based on the observation that the increasing regulation of conflicts of interest in medicine can have unintended and negative effects on the independence of science and scientific progress.
This project focuses on the factors that influence psychotherapy research and the distortions in publications of psychotherapy research.
Trustworthiness is an essential quality feature of clinical practice guidelines. Conflicts of interest due to relationships with manufacturers of drugs and medical devices, but also the self-interest of professionals, professional groups, and professional societies increase the risk of bias in clinical practice guidelines. Disclosure and management of conflicts of interest are therefore necessary. This project investigates how different actors perceive, assess and follow conflict of interest policies.
Manufacturers of pharmaceuticals and medical devices often declare patient welfare as their primary interest. Inevitably, conflicts arise with their obligation to safeguard the financial interests of their shareholders. This project addresses this conflict of interest and possible solutions.
So far, conflicts of interest have not been dealt with much in medical studies. We have developed an evidence-based curriculum on conflicts of interest and risk communication and made this teaching material freely available. The curriculum provides students with knowledge on the topic and teaches them to assess and communicate information correctly.
Our research interest also focuses on the distortions in the prescribing behavior of physicians and how these can be modified through certified continuing education and independent drug studies.